Misplaced Pages

Cardiac transient outward potassium current

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Ion current

The cardiac action potential has five phases. Ito1 is active during phase 1, causing a fast repolarization of the action potential

The cardiac transient outward potassium current (referred to as Ito1 or Ito ) is one of the ion currents across the cell membrane of heart muscle cells. It is the main contributing current during the repolarizing phase 1 of the cardiac action potential. It is a result of the movement of positively charged potassium (K) ions from the intracellular to the extracellular space. Ito1 is complemented with Ito2 resulting from Cl ions to form the transient outward current Ito.

Mechanism

Ito1 is rapidly activated and deactivated. It is activated after the fast increase of the membrane potential following the phase 0 of the cardiac action potential. Once activated, (K) ions from inside the cells flow to the extracellular space. This outward flow of positively charged ions constitutes the Ito1 and causes the transmembrane voltage to decrease. This decrease of the transmembrane potential is known as repolarization. Ito1 is then quickly deactivated, stopping the repolarization and ending the phase 1 of the action potential.

Ito1 is Ca-independent and has been clearly demonstrated in myocytes from different cardiac regions and species. There are two kinetic variants of cardiac Ito1: fast Ito1, called Ito1,f, and slow Ito, called Ito1,s. The channel responsible for Ito1,f is formed by assembly of Kv4.2 (KCND2) subunits, Kv4.3 (KCND3) subunits or a combination of the two, while the channel responsible for Ito1,s is composed of Kv1.4 (KCNA4) subunits. In addition, several regulatory subunits and pathways modulating the level and biophysical properties of cardiac Ito have been identified.

Ito1 affects the opening of Ca channels during Phase 2 of the Action Potential. As a result, changes in Ito1 modulate changes in the action potential duration.

Role in disease

  • Reduction in Ito1 density is associated with prolonged action potentials and is a common finding in cardiac disease .
  • Ito1 density is significantly lower in the cells of a failing heart in comparison to the cells of a healthy heart.
  • There is correlation between decreased Ito1 density and atrial fibrillation.
  • Ito activation is inhibited by thyrotropin (TSH). This mechanisms may be one of the reasons for the observation that both bradycardia and atrial fibrillation are common in hypothyroidism.
  • An increase in the Ito1 density caused by a mutation in Kv4.3 can be a cause of Brugada Syndrome.

References

  1. Niwa N, Nerbonne JM (January 2010). "Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation". Journal of Molecular and Cellular Cardiology. 48 (1): 12–25. doi:10.1016/j.yjmcc.2009.07.013. PMC 2813406. PMID 19619557.
  2. ^ Wettwer E, Amos G, Gath J, Zerkowski HR, Reidemeister JC, Ravens U (September 1993). "Transient outward current in human and rat ventricular myocytes". Cardiovascular Research. 27 (9): 1662–1669. doi:10.1093/cvr/27.9.1662. PMID 8287446.
  3. ^ Oudit GY, Kassiri Z, Sah R, Ramirez RJ, Zobel C, Backx PH (May 2001). "The molecular physiology of the cardiac transient outward potassium current (I(to)) in normal and diseased myocardium". Journal of Molecular and Cellular Cardiology. 33 (5): 851–872. doi:10.1006/jmcc.2001.1376. PMID 11343410. S2CID 829154.
  4. Beuckelmann DJ, Näbauer M, Erdmann E (August 1993). "Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure". Circulation Research. 73 (2): 379–385. doi:10.1161/01.RES.73.2.379. PMID 8330380.
  5. Brandt MC, Priebe L, Böhle T, Südkamp M, Beuckelmann DJ (October 2000). "The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation". Journal of Molecular and Cellular Cardiology. 32 (10): 1885–1896. doi:10.1006/jmcc.2000.1221. PMID 11013132.
  6. Alonso H, Fernández-Ruocco J, Gallego M, Malagueta-Vieira LL, Rodríguez-de-Yurre A, Medei E, et al. (December 2015). "Thyroid stimulating hormone directly modulates cardiac electrical activity". Journal of Molecular and Cellular Cardiology. 89 (Pt B): 280–286. doi:10.1016/j.yjmcc.2015.10.019. PMID 26497403.
  7. Müller P, Leow MK, Dietrich JW (15 August 2022). "Minor perturbations of thyroid homeostasis and major cardiovascular endpoints-Physiological mechanisms and clinical evidence". Frontiers in Cardiovascular Medicine. 9: 942971. doi:10.3389/fcvm.2022.942971. PMC 9420854. PMID 36046184.
  8. Zhang Y, Dedkov EI, Teplitsky D, Weltman NY, Pol CJ, Rajagopalan V, et al. (October 2013). "Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats". Circulation: Arrhythmia and Electrophysiology. 6 (5): 952–959. doi:10.1161/CIRCEP.113.000502. PMC 3973490. PMID 24036190.
  9. Kolettis TM, Tsatsoulis A (December 2012). "Subclinical Hypothyroidism: An Overlooked Cause of Atrial Fibrillation?". Journal of Atrial Fibrillation. 5 (4): 710. doi:10.4022/jafib.710 (inactive 1 November 2024). PMC 5153160. PMID 28496796.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  10. Giudicessi JR, Ye D, Tester DJ, Crotti L, Mugione A, Nesterenko VV, et al. (July 2011). "Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome". Heart Rhythm. 8 (7): 1024–1032. doi:10.1016/j.hrthm.2011.02.021. PMC 3150551. PMID 21349352.
Categories: